These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11025397)

  • 1. The synthetic metalloproteinase inhibitor batimastat suppresses injury-induced phosphorylation of MAP kinase ERK1/ERK2 and phenotypic modification of arterial smooth muscle cells in vitro.
    Lövdahl C; Thyberg J; Hultgârdh-Nilsson A
    J Vasc Res; 2000; 37(5):345-54. PubMed ID: 11025397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor.
    Zempo N; Koyama N; Kenagy RD; Lea HJ; Clowes AW
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):28-33. PubMed ID: 8548422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
    Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
    Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase can facilitate the heparanase-induced promotion of phenotype change in vascular smooth muscle cells.
    Fitzgerald M; Hayward IP; Thomas AC; Campbell GR; Campbell JH
    Atherosclerosis; 1999 Jul; 145(1):97-106. PubMed ID: 10428300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-type matrix metalloproteinase-1 and -3 activity in primate smooth muscle cells.
    Shofuda KI; Hasenstab D; Kenagy RD; Shofuda T; Li ZY; Lieber A; Clowes AW
    FASEB J; 2001 Sep; 15(11):2010-2. PubMed ID: 11511522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic modulation of arterial smooth muscle cells is associated with prolonged activation of ERK1/2.
    Roy J; Kazi M; Hedin U; Thyberg J
    Differentiation; 2001 Feb; 67(1-2):50-8. PubMed ID: 11270123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotides to stromelysin mRNA inhibit injury-induced proliferation of arterial smooth muscle cells.
    Lövdahl C; Thyberg J; Cercek B; Blomgren K; Dimayuga P; Kallin B; Hultgårdh-Nilsson A
    Histol Histopathol; 1999 Oct; 14(4):1101-12. PubMed ID: 10506926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
    Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
    J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Galphaq in smooth muscle cell proliferation.
    Tanski WJ; Roztocil E; Hemady EA; Williams JA; Davies MG
    J Vasc Surg; 2004 Mar; 39(3):639-44. PubMed ID: 14981460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smooth muscle cell response to mechanical injury involves intracellular calcium release and ERK1/ERK2 phosphorylation.
    Moses S; Dreja K; Lindqvist A; Lövdahl C; Hellstrand P; Hultgårdh-Nilsson A
    Exp Cell Res; 2001 Sep; 269(1):88-96. PubMed ID: 11525642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
    Nagata T; Kai H; Shibata R; Koga M; Yoshimura A; Imaizumi T
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):588-93. PubMed ID: 12615664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
    Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
    Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injury-induced osteopontin gene expression in rat arterial smooth muscle cells is dependent on mitogen-activated protein kinases ERK1/ERK2.
    Moses S; Franzén A; Lövdahl C; Hultgårdh-Nilsson A
    Arch Biochem Biophys; 2001 Dec; 396(1):133-7. PubMed ID: 11716472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active stromelysin-3 (MMP-11) increases MCF-7 survival in three-dimensional Matrigel culture via activation of p42/p44 MAP-kinase.
    Fromigué O; Louis K; Wu E; Belhacène N; Loubat A; Shipp M; Auberger P; Mari B
    Int J Cancer; 2003 Sep; 106(3):355-63. PubMed ID: 12845673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of hepatocyte growth factor-mediated vascular smooth muscle cell migration.
    Ma H; Calderon TM; Kessel T; Ashton AW; Berman JW
    Circ Res; 2003 Nov; 93(11):1066-73. PubMed ID: 14576199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pterostilbene Inhibits Vascular Smooth Muscle Cells Migration and Matrix Metalloproteinase-2 through Modulation of MAPK Pathway.
    Lin HC; Hsieh MJ; Peng CH; Yang SF; Huang CN
    J Food Sci; 2015 Oct; 80(10):H2331-5. PubMed ID: 26409033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 induces pulmonary but not aortic smooth muscle cell migration by activating ERK1/2 MAP kinase.
    Meoli DF; White RJ
    Can J Physiol Pharmacol; 2010 Aug; 88(8):830-9. PubMed ID: 20725141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin.
    Liu Y; Suzuki YJ; Day RM; Fanburg BL
    Circ Res; 2004 Sep; 95(6):579-86. PubMed ID: 15297378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury.
    Bendeck MP; Irvin C; Reidy MA
    Circ Res; 1996 Jan; 78(1):38-43. PubMed ID: 8603503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.